DNA Script Advances Evaluation Program for the SYNTAX System, the First Benchtop DNA Printer Powered By Enzymatic Synthesis
USA - English
Share this article
Share this article
The SYNTAX System Delivers DNA On Demand to Enable Labs to Control Their Workflow, Innovate Faster
SOUTH SAN FRANCISCO, Calif., and PARIS, May 20, 2021 /PRNewswire/ DNA Script, a leading pioneer in enabling enzymatic DNA synthesis on demand, today announced the third and final phase of its evaluation program for the SYNTAX System, the world s first benchtop printer powered by Enzymatic DNA Synthesis (EDS) technology. This SYNTAX instrument is designed to require less than 15 minutes of hands-on setup and synthesize DNA in as little as six hours, producing 96 ready-to-use oligos in parallel.
DNA Script Partners with Moderna to Develop On-Demand Vaccines and Therapeutics for DARPA
zazoom.it - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from zazoom.it Daily Mail and Mail on Sunday newspapers.
DNA Script se asocia con Moderna para desarrollar vacunas bajo demanda y productos terapéuticos para DARPA
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Share this article
Share this article
PROVIDENCE, R.I., March 31, 2021 /PRNewswire/ Ximedica today announced a partnership with Moderna, Inc. (Nasdaq: MRNA) to develop a prototype for rapid mobile manufacturing of vaccines and therapeutics as part of the Defense Advanced Research Projects Agency s (DARPA) Nucleic Acids On-Demand World-Wide (NOW) Program. Integrating Moderna s proprietary mRNA technology with Ximedica s instrument design and engineering expertise, both teams will work closely together in an effort to meet capability expectations set out by the DARPA program over the 4-year partnership. As part of the agreement, Ximedica will receive up to $11 million in funding.
DARPA s Nucleic Acids On-Demand World-Wide initiative aims to develop a mobile, just-in-time manufacturing platform that quickly diagnoses pathogen threats and provides medical countermeasures to deliver pandemic prevention treatments in-field. The resulting Good Manufacturing Practice (GMP) quality mRN